Table of Content


1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Geriatric Population
4.2.2 Growing Prevalence of Spine Deformities
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Reimbursement Policies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Bone Graft Substitutes
5.1.1.1 Bone Morphogenetic Proteins
5.1.1.2 Synthetic Bone Grafts
5.1.2 Spinal Allografts
5.1.2.1 Machined Bones Allograft
5.1.2.2 Demineralized Bone Matrix
5.1.3 Others
5.2 By End User
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 DePuy Synthes (Johnson and Johnson)
6.1.2 Orthofix Medical Inc.
6.1.3 Stryker
6.1.4 Zimmer Biomet
6.1.5 Arthrex, Inc.
6.1.6 Exactech, Inc
6.1.7 Wright Medical Group N.V
6.1.8 Medtronic plc
6.1.9 NuVasive, Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS